Drug Type Gut microbiota |
Synonyms 14-species commensal bacterial flora with prebiotics and postbiotic complex composed of gut microbiome modulating formulation + [1] |
Target- |
Action modulators |
Mechanism Gastrointestinal microbiome modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Angelman Syndrome | Preclinical | United States | 29 Apr 2024 |